Cloud Alpha Capital Management Limited Caribou Biosciences, Inc. Transaction History

Cloud Alpha Capital Management Limited

  • $1.68 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$8.42 - $15.32 $3.49 Million - $6.36 Million
-415,000 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$14.59 - $23.26 $1.6 Million - $2.56 Million
110,000 Added 36.07%
415,000 $6.26 Million
Q3 2021

Nov 12, 2021
BUY
$15.75 - $30.29 $4.8 Million - $9.24 Million
305,000 New
305,000 $7.28 Million

Others Institutions Holding CRBU

# of Institutions
141
Shares Held
53.3M
Call Options Held
32.5K
Put Options Held
89.8K
View Full List

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $156M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Cloud Alpha Capital Management Limited Portfolio

Follow Cloud Alpha Capital Management Limited and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloud Alpha Capital Management Limited, based on Form 13F filings with the SEC.

News

Stay updated on Cloud Alpha Capital Management Limited with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email